

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline biosynthetic process (GO:0006561) | 6.21465772 |
| 2 | DNA deamination (GO:0045006) | 6.09295979 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.95432427 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.95432427 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.89532280 |
| 6 | proline metabolic process (GO:0006560) | 4.85301242 |
| 7 | cellular response to zinc ion (GO:0071294) | 4.62473655 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.60412021 |
| 9 | positive regulation of protein homooligomerization (GO:0032464) | 4.53899787 |
| 10 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.48819968 |
| 11 | replication fork processing (GO:0031297) | 4.29482007 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.19981336 |
| 13 | transcription from mitochondrial promoter (GO:0006390) | 4.17152250 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.05488678 |
| 15 | embryonic process involved in female pregnancy (GO:0060136) | 4.01951788 |
| 16 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 4.01012558 |
| 17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.98388158 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 3.72709570 |
| 19 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.56229600 |
| 20 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.55313207 |
| 21 | UV protection (GO:0009650) | 3.54344399 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.50555407 |
| 23 | regulation of B cell differentiation (GO:0045577) | 3.49112152 |
| 24 | positive regulation of B cell differentiation (GO:0045579) | 3.46454290 |
| 25 | negative regulation of cell size (GO:0045792) | 3.46369906 |
| 26 | regulation of protein homooligomerization (GO:0032462) | 3.44236332 |
| 27 | modulation by virus of host process (GO:0019054) | 3.42578833 |
| 28 | mannose metabolic process (GO:0006013) | 3.41877203 |
| 29 | protein maturation by protein folding (GO:0022417) | 3.40120430 |
| 30 | mitochondrial DNA metabolic process (GO:0032042) | 3.36294096 |
| 31 | B cell receptor signaling pathway (GO:0050853) | 3.35488417 |
| 32 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.32556966 |
| 33 | response to peptidoglycan (GO:0032494) | 3.23848465 |
| 34 | positive regulation of lamellipodium assembly (GO:0010592) | 3.23436918 |
| 35 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.21243015 |
| 36 | barbed-end actin filament capping (GO:0051016) | 3.18666881 |
| 37 | DNA strand renaturation (GO:0000733) | 3.18397939 |
| 38 | leukocyte aggregation (GO:0070486) | 3.15304424 |
| 39 | neutrophil activation involved in immune response (GO:0002283) | 3.13490807 |
| 40 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.12914094 |
| 41 | modulation by symbiont of host cellular process (GO:0044068) | 3.12199992 |
| 42 | oxidative demethylation (GO:0070989) | 3.11933635 |
| 43 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.11611575 |
| 44 | heme biosynthetic process (GO:0006783) | 3.10940675 |
| 45 | positive regulation of protein oligomerization (GO:0032461) | 3.10543060 |
| 46 | ribosomal small subunit assembly (GO:0000028) | 3.09346040 |
| 47 | immunoglobulin mediated immune response (GO:0016064) | 3.08316841 |
| 48 | viral mRNA export from host cell nucleus (GO:0046784) | 3.06359051 |
| 49 | protein retention in ER lumen (GO:0006621) | 3.04541570 |
| 50 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.04262222 |
| 51 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.04262222 |
| 52 | adenosine receptor signaling pathway (GO:0001973) | 3.03695892 |
| 53 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.03565123 |
| 54 | negative regulation of cell killing (GO:0031342) | 3.01602682 |
| 55 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.01602682 |
| 56 | regulation of mast cell degranulation (GO:0043304) | 3.00946620 |
| 57 | positive thymic T cell selection (GO:0045059) | 2.99976169 |
| 58 | viral protein processing (GO:0019082) | 2.99859832 |
| 59 | negative regulation of stress fiber assembly (GO:0051497) | 2.98421741 |
| 60 | cellular response to virus (GO:0098586) | 2.98274310 |
| 61 | pinocytosis (GO:0006907) | 2.93402709 |
| 62 | negative thymic T cell selection (GO:0045060) | 2.93346862 |
| 63 | pentose-phosphate shunt (GO:0006098) | 2.91005453 |
| 64 | T cell migration (GO:0072678) | 2.90778904 |
| 65 | positive regulation of lamellipodium organization (GO:1902745) | 2.90218273 |
| 66 | regulation of integrin activation (GO:0033623) | 2.89939537 |
| 67 | pentose metabolic process (GO:0019321) | 2.89691724 |
| 68 | dosage compensation (GO:0007549) | 2.89245457 |
| 69 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.88916381 |
| 70 | telomere maintenance via recombination (GO:0000722) | 2.88311686 |
| 71 | negative T cell selection (GO:0043383) | 2.87393124 |
| 72 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.86920043 |
| 73 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.85337557 |
| 74 | regulation of necrotic cell death (GO:0010939) | 2.80035957 |
| 75 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.78138578 |
| 76 | positive regulation by symbiont of host defense response (GO:0052509) | 2.77216180 |
| 77 | modulation by symbiont of host defense response (GO:0052031) | 2.77216180 |
| 78 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.77216180 |
| 79 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.77216180 |
| 80 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.77216180 |
| 81 | modulation by symbiont of host immune response (GO:0052553) | 2.77216180 |
| 82 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.75971187 |
| 83 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.75074913 |
| 84 | virion assembly (GO:0019068) | 2.74590268 |
| 85 | apoptotic process involved in morphogenesis (GO:0060561) | 2.73105809 |
| 86 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.71906156 |
| 87 | glucose catabolic process (GO:0006007) | 2.71147707 |
| 88 | negative regulation of interleukin-12 production (GO:0032695) | 2.70678622 |
| 89 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.70517328 |
| 90 | heme metabolic process (GO:0042168) | 2.70298470 |
| 91 | amyloid precursor protein catabolic process (GO:0042987) | 2.70250390 |
| 92 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.70196424 |
| 93 | lipoxygenase pathway (GO:0019372) | 2.69744369 |
| 94 | defense response to protozoan (GO:0042832) | 2.67491888 |
| 95 | regulation of leukocyte degranulation (GO:0043300) | 2.67179447 |
| 96 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.67133349 |
| 97 | response to type I interferon (GO:0034340) | 2.66131821 |
| 98 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.65736995 |
| 99 | type I interferon signaling pathway (GO:0060337) | 2.64770994 |
| 100 | cellular response to type I interferon (GO:0071357) | 2.64770994 |
| 101 | base-excision repair (GO:0006284) | 2.64326108 |
| 102 | regulation of protein oligomerization (GO:0032459) | 2.64286461 |
| 103 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.62471990 |
| 104 | detection of bacterium (GO:0016045) | 2.61956447 |
| 105 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.61777355 |
| 106 | negative regulation of cell cycle arrest (GO:0071157) | 2.60662720 |
| 107 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.60042452 |
| 108 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.58934049 |
| 109 | pyrimidine nucleoside salvage (GO:0043097) | 2.58920213 |
| 110 | pyrimidine-containing compound salvage (GO:0008655) | 2.58920213 |
| 111 | mature B cell differentiation involved in immune response (GO:0002313) | 2.58349203 |
| 112 | positive regulation of histone deacetylation (GO:0031065) | 2.58267700 |
| 113 | mRNA cleavage (GO:0006379) | 2.57970985 |
| 114 | mitochondrial DNA replication (GO:0006264) | 2.56352211 |
| 115 | NIK/NF-kappaB signaling (GO:0038061) | 2.56323186 |
| 116 | negative regulation of protein oligomerization (GO:0032460) | 2.56182183 |
| 117 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.56070083 |
| 118 | response to protozoan (GO:0001562) | 2.56046244 |
| 119 | leukocyte cell-cell adhesion (GO:0007159) | 2.54515165 |
| 120 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.54075980 |
| 121 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.53928859 |
| 122 | negative regulation of RNA splicing (GO:0033119) | 2.52422895 |
| 123 | DNA strand elongation (GO:0022616) | 2.52415357 |
| 124 | B cell mediated immunity (GO:0019724) | 2.50281478 |
| 125 | nucleotide salvage (GO:0043173) | 2.49960406 |
| 126 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.48664345 |
| 127 | negative regulation of phagocytosis (GO:0050765) | 2.48060353 |
| 128 | positive regulation of odontogenesis (GO:0042482) | 2.47723993 |
| 129 | cellular response to interferon-beta (GO:0035458) | 2.47122549 |
| 130 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.46943903 |
| 131 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.46663647 |
| 132 | thymic T cell selection (GO:0045061) | 2.45535197 |
| 133 | retinoic acid receptor signaling pathway (GO:0048384) | 2.45411319 |
| 134 | GDP-mannose metabolic process (GO:0019673) | 2.45319332 |
| 135 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.45209963 |
| 136 | response to interleukin-15 (GO:0070672) | 2.44755062 |
| 137 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.44487089 |
| 138 | detection of other organism (GO:0098543) | 2.44306346 |
| 139 | stress fiber assembly (GO:0043149) | 2.44204842 |
| 140 | formation of translation preinitiation complex (GO:0001731) | 2.43232786 |
| 141 | deoxyribonucleotide catabolic process (GO:0009264) | 2.42167734 |
| 142 | sequestering of actin monomers (GO:0042989) | 2.41820706 |
| 143 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.41341053 |
| 144 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.40296671 |
| 145 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.40296671 |
| 146 | telomere maintenance via telomere lengthening (GO:0010833) | 2.39819625 |
| 147 | mature B cell differentiation (GO:0002335) | 2.39716789 |
| 148 | viral transcription (GO:0019083) | 2.39533528 |
| 149 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.39505813 |
| 150 | mitotic recombination (GO:0006312) | 2.39114482 |
| 151 | regulation of lamellipodium assembly (GO:0010591) | 2.38910617 |
| 152 | regulation of defense response to virus by virus (GO:0050690) | 2.38299942 |
| 153 | response to interferon-beta (GO:0035456) | 2.37198371 |
| 154 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.37107362 |
| 155 | amino sugar catabolic process (GO:0046348) | 2.36736072 |
| 156 | regulation of response to interferon-gamma (GO:0060330) | 2.36268290 |
| 157 | embryonic placenta development (GO:0001892) | 2.35570597 |
| 158 | mitotic G1/S transition checkpoint (GO:0044819) | 2.34555548 |
| 159 | regulation of superoxide anion generation (GO:0032928) | 2.34284105 |
| 160 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.33506904 |
| 161 | positive regulation of protein deacetylation (GO:0090312) | 2.33291588 |
| 162 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.33060962 |
| 163 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.32840371 |
| 164 | NADPH regeneration (GO:0006740) | 2.32166744 |
| 165 | protein localization to endosome (GO:0036010) | 2.31942185 |
| 166 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.31426797 |
| 167 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.31001391 |
| 168 | COPI coating of Golgi vesicle (GO:0048205) | 2.29224937 |
| 169 | Golgi transport vesicle coating (GO:0048200) | 2.29224937 |
| 170 | modulation by virus of host morphology or physiology (GO:0019048) | 2.28529034 |
| 171 | amyloid precursor protein metabolic process (GO:0042982) | 2.28426757 |
| 172 | oxygen transport (GO:0015671) | 2.28312765 |
| 173 | negative regulation of viral release from host cell (GO:1902187) | 2.28210944 |
| 174 | regulation of tumor necrosis factor production (GO:0032680) | 2.27346132 |
| 175 | activation of MAPKKK activity (GO:0000185) | 2.26711351 |
| 176 | negative regulation of necroptotic process (GO:0060546) | 2.26423626 |
| 177 | hyaluronan catabolic process (GO:0030214) | 2.23887597 |
| 178 | deoxyribose phosphate catabolic process (GO:0046386) | 2.23537076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.34868749 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.27525063 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.22180281 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 2.90197328 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.69976010 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.66480208 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.50385145 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.42725572 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.41756944 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.39283190 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.33389978 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.27396001 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26673602 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.19131746 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.17544186 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.11255375 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.09185050 |
| 18 | P68_20966046_ChIP-Seq_HELA_Human | 1.98144587 |
| 19 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96178681 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90065558 |
| 21 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88906490 |
| 22 | UTX_26944678_Chip-Seq_JUKART_Human | 1.88906277 |
| 23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.84046331 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.83320153 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.81960889 |
| 26 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.79583508 |
| 27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.79326557 |
| 28 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.73643090 |
| 29 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.72211872 |
| 30 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.71596298 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 1.69515028 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.69217130 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.68357288 |
| 34 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.67604439 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.66937257 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.65645656 |
| 37 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.63701702 |
| 38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.63319614 |
| 39 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.62555613 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.62550241 |
| 41 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.62096272 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.61975927 |
| 43 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61509864 |
| 44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.59810940 |
| 45 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.58678016 |
| 46 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.57089227 |
| 47 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.56772356 |
| 48 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.55172072 |
| 49 | MYB_26560356_Chip-Seq_TH2_Human | 1.54749781 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.54558775 |
| 51 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.54086000 |
| 52 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53548617 |
| 53 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.51495971 |
| 54 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.49736094 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48513467 |
| 56 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.46763784 |
| 57 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.45210382 |
| 58 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.44821163 |
| 59 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.44359496 |
| 60 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42726392 |
| 61 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42346297 |
| 62 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.41423729 |
| 63 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.41004443 |
| 64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.39718512 |
| 65 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.38570663 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38265205 |
| 67 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.38169940 |
| 68 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.37688998 |
| 69 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.35691273 |
| 70 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.35657502 |
| 71 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.34902276 |
| 72 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34639213 |
| 73 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32940443 |
| 74 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.32436829 |
| 75 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.32006204 |
| 76 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31501219 |
| 77 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.31180074 |
| 78 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.30501045 |
| 79 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.27999780 |
| 80 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.27620741 |
| 81 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.27391318 |
| 82 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27369275 |
| 83 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.27199118 |
| 84 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.26582785 |
| 85 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.25631254 |
| 86 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.25137054 |
| 87 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.24632894 |
| 88 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.24611369 |
| 89 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23893515 |
| 90 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.23836262 |
| 91 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.23509498 |
| 92 | KDM2B_26808549_Chip-Seq_K562_Human | 1.22911877 |
| 93 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.22485778 |
| 94 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.22219157 |
| 95 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21947685 |
| 96 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.21802104 |
| 97 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.21529735 |
| 98 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.18594334 |
| 99 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.18533035 |
| 100 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.18472494 |
| 101 | SA1_27219007_Chip-Seq_Bcells_Human | 1.18019630 |
| 102 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.16073735 |
| 103 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15491189 |
| 104 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.15272715 |
| 105 | GATA1_22025678_ChIP-Seq_K562_Human | 1.14924158 |
| 106 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.14260494 |
| 107 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14165847 |
| 108 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.13379630 |
| 109 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13302354 |
| 110 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.13152992 |
| 111 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13126132 |
| 112 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.12970014 |
| 113 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.12509304 |
| 114 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.12478602 |
| 115 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.12425235 |
| 116 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.12059651 |
| 117 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.11702192 |
| 118 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11669578 |
| 119 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.10904552 |
| 120 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.10827330 |
| 121 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10803017 |
| 122 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10565950 |
| 123 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10540788 |
| 124 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.10407035 |
| 125 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09912623 |
| 126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09528229 |
| 127 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08227428 |
| 128 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.08216546 |
| 129 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08208290 |
| 130 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.07880434 |
| 131 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.07638149 |
| 132 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.07636259 |
| 133 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07469256 |
| 134 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07181818 |
| 135 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.06920930 |
| 136 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.06867282 |
| 137 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.06675589 |
| 138 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06400650 |
| 139 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.06335568 |
| 140 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.05938986 |
| 141 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.04735962 |
| 142 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04650203 |
| 143 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03494779 |
| 144 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.02946444 |
| 145 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.02704169 |
| 146 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02082071 |
| 147 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.01174680 |
| 148 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.01161658 |
| 149 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00838709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 4.29935700 |
| 2 | MP0000685_abnormal_immune_system | 3.51854763 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.34191711 |
| 4 | MP0009278_abnormal_bone_marrow | 2.87523917 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.83422912 |
| 6 | MP0002166_altered_tumor_susceptibility | 2.69459510 |
| 7 | MP0008260_abnormal_autophagy | 2.64123957 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.60048691 |
| 9 | * MP0001800_abnormal_humoral_immune | 2.59005030 |
| 10 | MP0005671_abnormal_response_to | 2.49326405 |
| 11 | MP0005397_hematopoietic_system_phenotyp | 2.48557316 |
| 12 | MP0001545_abnormal_hematopoietic_system | 2.48557316 |
| 13 | MP0008057_abnormal_DNA_replication | 2.47018042 |
| 14 | MP0003436_decreased_susceptibility_to | 2.40487932 |
| 15 | MP0009785_altered_susceptibility_to | 2.35011446 |
| 16 | MP0005387_immune_system_phenotype | 2.34639696 |
| 17 | MP0001790_abnormal_immune_system | 2.34639696 |
| 18 | * MP0002398_abnormal_bone_marrow | 2.26171357 |
| 19 | * MP0002452_abnormal_antigen_presenting | 2.21734921 |
| 20 | * MP0002723_abnormal_immune_serum | 2.16537943 |
| 21 | MP0005000_abnormal_immune_tolerance | 2.12642243 |
| 22 | * MP0002420_abnormal_adaptive_immunity | 2.10789776 |
| 23 | * MP0000689_abnormal_spleen_morphology | 2.08551101 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.08506788 |
| 25 | * MP0001819_abnormal_immune_cell | 2.07404681 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 2.05404496 |
| 27 | * MP0002405_respiratory_system_inflammati | 2.04774118 |
| 28 | MP0005025_abnormal_response_to | 2.03659339 |
| 29 | MP0005174_abnormal_tail_pigmentation | 1.97888757 |
| 30 | MP0002006_tumorigenesis | 1.97423033 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 1.96410346 |
| 32 | * MP0000716_abnormal_immune_system | 1.96231466 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.95612716 |
| 34 | MP0005058_abnormal_lysosome_morphology | 1.89707077 |
| 35 | * MP0002722_abnormal_immune_system | 1.86205840 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.85869375 |
| 37 | MP0005670_abnormal_white_adipose | 1.83389493 |
| 38 | MP0002419_abnormal_innate_immunity | 1.82071170 |
| 39 | MP0000678_abnormal_parathyroid_gland | 1.78272055 |
| 40 | * MP0002429_abnormal_blood_cell | 1.74960281 |
| 41 | MP0002148_abnormal_hypersensitivity_rea | 1.73504383 |
| 42 | MP0000751_myopathy | 1.65616253 |
| 43 | MP0004858_abnormal_nervous_system | 1.62442877 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.59774996 |
| 45 | MP0003656_abnormal_erythrocyte_physiolo | 1.59320962 |
| 46 | MP0000703_abnormal_thymus_morphology | 1.59205695 |
| 47 | MP0002009_preneoplasia | 1.58375255 |
| 48 | MP0005365_abnormal_bile_salt | 1.56596565 |
| 49 | MP0006082_CNS_inflammation | 1.56445488 |
| 50 | MP0003866_abnormal_defecation | 1.55820353 |
| 51 | * MP0001845_abnormal_inflammatory_respons | 1.54510383 |
| 52 | MP0000490_abnormal_crypts_of | 1.52613927 |
| 53 | MP0001853_heart_inflammation | 1.47842727 |
| 54 | MP0005666_abnormal_adipose_tissue | 1.41120754 |
| 55 | MP0005085_abnormal_gallbladder_physiolo | 1.40383199 |
| 56 | MP0004808_abnormal_hematopoietic_stem | 1.39368019 |
| 57 | MP0005075_abnormal_melanosome_morpholog | 1.38027608 |
| 58 | MP0001849_ear_inflammation | 1.37654255 |
| 59 | MP0010094_abnormal_chromosome_stability | 1.36429349 |
| 60 | MP0005375_adipose_tissue_phenotype | 1.36231932 |
| 61 | MP0003303_peritoneal_inflammation | 1.35479950 |
| 62 | MP0003279_aneurysm | 1.34464249 |
| 63 | MP0008469_abnormal_protein_level | 1.33748965 |
| 64 | MP0002019_abnormal_tumor_incidence | 1.32891861 |
| 65 | MP0000750_abnormal_muscle_regeneration | 1.32220340 |
| 66 | MP0000003_abnormal_adipose_tissue | 1.30504518 |
| 67 | MP0005501_abnormal_skin_physiology | 1.29853265 |
| 68 | MP0000465_gastrointestinal_hemorrhage | 1.29343621 |
| 69 | * MP0001873_stomach_inflammation | 1.28579951 |
| 70 | MP0003300_gastrointestinal_ulcer | 1.26098903 |
| 71 | MP0005410_abnormal_fertilization | 1.25347627 |
| 72 | MP0006036_abnormal_mitochondrial_physio | 1.25226137 |
| 73 | MP0005083_abnormal_biliary_tract | 1.24981747 |
| 74 | MP0003329_amyloid_beta_deposits | 1.24726943 |
| 75 | MP0003075_altered_response_to | 1.23226528 |
| 76 | MP0003724_increased_susceptibility_to | 1.22685715 |
| 77 | * MP0004947_skin_inflammation | 1.20718981 |
| 78 | MP0004185_abnormal_adipocyte_glucose | 1.15759592 |
| 79 | MP0000015_abnormal_ear_pigmentation | 1.14723246 |
| 80 | MP0005360_urolithiasis | 1.13496200 |
| 81 | MP0009840_abnormal_foam_cell | 1.12027095 |
| 82 | MP0005330_cardiomyopathy | 1.11903871 |
| 83 | MP0008058_abnormal_DNA_repair | 1.10557014 |
| 84 | MP0000609_abnormal_liver_physiology | 1.08251303 |
| 85 | MP0003566_abnormal_cell_adhesion | 1.07282430 |
| 86 | MP0010352_gastrointestinal_tract_polyps | 1.06145476 |
| 87 | MP0000371_diluted_coat_color | 1.05559577 |
| 88 | MP0004510_myositis | 1.02994341 |
| 89 | MP0002796_impaired_skin_barrier | 1.02177766 |
| 90 | MP0005166_decreased_susceptibility_to | 1.01354943 |
| 91 | MP0003191_abnormal_cellular_cholesterol | 0.99640683 |
| 92 | MP0000681_abnormal_thyroid_gland | 0.98566397 |
| 93 | MP0005076_abnormal_cell_differentiation | 0.98088922 |
| 94 | MP0003111_abnormal_nucleus_morphology | 0.96382034 |
| 95 | MP0000858_altered_metastatic_potential | 0.94923798 |
| 96 | MP0008874_decreased_physiological_sensi | 0.94148277 |
| 97 | MP0002332_abnormal_exercise_endurance | 0.94117196 |
| 98 | MP0005390_skeleton_phenotype | 0.93679968 |
| 99 | MP0004381_abnormal_hair_follicle | 0.91669337 |
| 100 | MP0004957_abnormal_blastocyst_morpholog | 0.89669082 |
| 101 | MP0002249_abnormal_larynx_morphology | 0.89358282 |
| 102 | MP0000313_abnormal_cell_death | 0.89240621 |
| 103 | MP0000749_muscle_degeneration | 0.89191552 |
| 104 | MP0000604_amyloidosis | 0.88904721 |
| 105 | * MP0000598_abnormal_liver_morphology | 0.88407340 |
| 106 | MP0003693_abnormal_embryo_hatching | 0.87814827 |
| 107 | * MP0002933_joint_inflammation | 0.87713123 |
| 108 | MP0002998_abnormal_bone_remodeling | 0.87198818 |
| 109 | MP0009764_decreased_sensitivity_to | 0.86685513 |
| 110 | MP0000759_abnormal_skeletal_muscle | 0.86671789 |
| 111 | MP0002653_abnormal_ependyma_morphology | 0.85875844 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 0.85397386 |
| 113 | MP0001533_abnormal_skeleton_physiology | 0.82991104 |
| 114 | * MP0009931_abnormal_skin_appearance | 0.82045252 |
| 115 | MP0002132_abnormal_respiratory_system | 0.80837693 |
| 116 | MP0003077_abnormal_cell_cycle | 0.80359897 |
| 117 | MP0000747_muscle_weakness | 0.79755227 |
| 118 | MP0002138_abnormal_hepatobiliary_system | 0.78971691 |
| 119 | MP0002139_abnormal_hepatobiliary_system | 0.78786954 |
| 120 | MP0000343_altered_response_to | 0.77739507 |
| 121 | * MP0003453_abnormal_keratinocyte_physiol | 0.76347945 |
| 122 | MP0000013_abnormal_adipose_tissue | 0.75993992 |
| 123 | MP0001666_abnormal_nutrient_absorption | 0.75978164 |
| 124 | MP0004233_abnormal_muscle_weight | 0.75093587 |
| 125 | MP0005023_abnormal_wound_healing | 0.74810732 |
| 126 | MP0000249_abnormal_blood_vessel | 0.74179696 |
| 127 | MP0003186_abnormal_redox_activity | 0.72547800 |
| 128 | MP0010307_abnormal_tumor_latency | 0.72192998 |
| 129 | MP0003045_fibrosis | 0.71533683 |
| 130 | MP0002269_muscular_atrophy | 0.71194902 |
| 131 | MP0003943_abnormal_hepatobiliary_system | 0.70617776 |
| 132 | MP0003183_abnormal_peptide_metabolism | 0.69134359 |
| 133 | MP0002928_abnormal_bile_duct | 0.68870597 |
| 134 | MP0003448_altered_tumor_morphology | 0.68221766 |
| 135 | MP0009763_increased_sensitivity_to | 0.65443741 |
| 136 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.65178732 |
| 137 | MP0009115_abnormal_fat_cell | 0.65000632 |
| 138 | MP0003828_pulmonary_edema | 0.63911660 |
| 139 | MP0005310_abnormal_salivary_gland | 0.63572001 |
| 140 | MP0002970_abnormal_white_adipose | 0.63320885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pustule (HP:0200039) | 5.50474769 |
| 2 | IgM deficiency (HP:0002850) | 4.67721090 |
| 3 | Poikiloderma (HP:0001029) | 4.04487070 |
| 4 | Increased IgM level (HP:0003496) | 3.90821073 |
| 5 | Recurrent fungal infections (HP:0002841) | 3.73403596 |
| 6 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.67830085 |
| 7 | Recurrent bronchitis (HP:0002837) | 3.63101029 |
| 8 | IgA deficiency (HP:0002720) | 3.62337337 |
| 9 | Recurrent abscess formation (HP:0002722) | 3.45743955 |
| 10 | Abnormality of T cell physiology (HP:0011840) | 3.41958853 |
| 11 | IgG deficiency (HP:0004315) | 3.37540933 |
| 12 | Colitis (HP:0002583) | 3.33596648 |
| 13 | Gastrointestinal inflammation (HP:0004386) | 3.31081885 |
| 14 | Eczematoid dermatitis (HP:0000976) | 3.30104669 |
| 15 | Inflammation of the large intestine (HP:0002037) | 3.28620689 |
| 16 | Abnormality of T cells (HP:0002843) | 3.24759375 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 3.23917138 |
| 18 | Recurrent viral infections (HP:0004429) | 3.23300262 |
| 19 | Distal lower limb muscle weakness (HP:0009053) | 3.21539956 |
| 20 | Mucopolysacchariduria (HP:0008155) | 3.20902227 |
| 21 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.20902227 |
| 22 | Dysostosis multiplex (HP:0000943) | 3.17317041 |
| 23 | Agammaglobulinemia (HP:0004432) | 3.11747973 |
| 24 | Purpura (HP:0000979) | 3.09590636 |
| 25 | Recurrent bacterial skin infections (HP:0005406) | 3.07190247 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.06569276 |
| 27 | Increased serum ferritin (HP:0003281) | 3.05874005 |
| 28 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.01190350 |
| 29 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.01190350 |
| 30 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.01190350 |
| 31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.01091451 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 2.98224555 |
| 33 | Obstructive lung disease (HP:0006536) | 2.98224555 |
| 34 | Myopathic facies (HP:0002058) | 2.95709126 |
| 35 | Vertebral compression fractures (HP:0002953) | 2.94318419 |
| 36 | Petechiae (HP:0000967) | 2.91596648 |
| 37 | Albinism (HP:0001022) | 2.90596584 |
| 38 | Chronic otitis media (HP:0000389) | 2.90191379 |
| 39 | Thrombocytosis (HP:0001894) | 2.89681549 |
| 40 | Vacuolated lymphocytes (HP:0001922) | 2.87394552 |
| 41 | Bulbar palsy (HP:0001283) | 2.84260339 |
| 42 | Myositis (HP:0100614) | 2.82281011 |
| 43 | Meningitis (HP:0001287) | 2.81708456 |
| 44 | Squamous cell carcinoma (HP:0002860) | 2.80003455 |
| 45 | Hypertensive crisis (HP:0100735) | 2.71958298 |
| 46 | Prolonged bleeding time (HP:0003010) | 2.71619044 |
| 47 | Reticulocytosis (HP:0001923) | 2.71303481 |
| 48 | Ragged-red muscle fibers (HP:0003200) | 2.67729462 |
| 49 | Abnormality of T cell number (HP:0011839) | 2.64071909 |
| 50 | T lymphocytopenia (HP:0005403) | 2.63401912 |
| 51 | Lymphoma (HP:0002665) | 2.57241586 |
| 52 | Recurrent cutaneous fungal infections (HP:0011370) | 2.56060693 |
| 53 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.56060693 |
| 54 | Cellulitis (HP:0100658) | 2.55566242 |
| 55 | Severe combined immunodeficiency (HP:0004430) | 2.53607800 |
| 56 | Autoimmune thrombocytopenia (HP:0001973) | 2.52442887 |
| 57 | Increased connective tissue (HP:0009025) | 2.50800281 |
| 58 | Abnormality of B cell number (HP:0010975) | 2.50195773 |
| 59 | B lymphocytopenia (HP:0010976) | 2.50195773 |
| 60 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.50039865 |
| 61 | Gastrointestinal stroma tumor (HP:0100723) | 2.49947132 |
| 62 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.48351263 |
| 63 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.46567627 |
| 64 | Recurrent skin infections (HP:0001581) | 2.45045835 |
| 65 | Cheilitis (HP:0100825) | 2.43948487 |
| 66 | Distal lower limb amyotrophy (HP:0008944) | 2.43440570 |
| 67 | Epistaxis (HP:0000421) | 2.41938588 |
| 68 | Basal cell carcinoma (HP:0002671) | 2.41719742 |
| 69 | Lymphopenia (HP:0001888) | 2.41254715 |
| 70 | Hypertriglyceridemia (HP:0002155) | 2.40969255 |
| 71 | Hypochromic anemia (HP:0001931) | 2.40421307 |
| 72 | Hypergammaglobulinemia (HP:0010702) | 2.40416853 |
| 73 | Increased cerebral lipofuscin (HP:0011813) | 2.40056180 |
| 74 | Abnormality of iron homeostasis (HP:0011031) | 2.39343758 |
| 75 | Nasal polyposis (HP:0100582) | 2.38448068 |
| 76 | Combined immunodeficiency (HP:0005387) | 2.38058327 |
| 77 | Polycythemia (HP:0001901) | 2.37668946 |
| 78 | Abnormal gallbladder physiology (HP:0012438) | 2.37030134 |
| 79 | Cholecystitis (HP:0001082) | 2.37030134 |
| 80 | Cholelithiasis (HP:0001081) | 2.36814825 |
| 81 | Mediastinal lymphadenopathy (HP:0100721) | 2.35665787 |
| 82 | Abnormality of the nasal mucosa (HP:0000433) | 2.33645956 |
| 83 | Papilloma (HP:0012740) | 2.33351049 |
| 84 | Verrucae (HP:0200043) | 2.33351049 |
| 85 | Abnormal platelet volume (HP:0011876) | 2.32675336 |
| 86 | Asymmetric septal hypertrophy (HP:0001670) | 2.32273322 |
| 87 | Abnormality of glycolipid metabolism (HP:0010969) | 2.30289489 |
| 88 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.30289489 |
| 89 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.30289489 |
| 90 | Joint stiffness (HP:0001387) | 2.29899098 |
| 91 | Loss of speech (HP:0002371) | 2.29404111 |
| 92 | Upper limb amyotrophy (HP:0009129) | 2.28035126 |
| 93 | Distal upper limb amyotrophy (HP:0007149) | 2.28035126 |
| 94 | Vasculitis (HP:0002633) | 2.26613261 |
| 95 | Hemorrhage of the eye (HP:0011885) | 2.26299045 |
| 96 | Exercise-induced myalgia (HP:0003738) | 2.25971945 |
| 97 | Easy fatigability (HP:0003388) | 2.25763416 |
| 98 | Cervical subluxation (HP:0003308) | 2.25695392 |
| 99 | Thyroiditis (HP:0100646) | 2.25424721 |
| 100 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.25197076 |
| 101 | Spontaneous hematomas (HP:0007420) | 2.24042090 |
| 102 | Stridor (HP:0010307) | 2.22476506 |
| 103 | Cerebral palsy (HP:0100021) | 2.18062415 |
| 104 | Hepatosplenomegaly (HP:0001433) | 2.16796744 |
| 105 | Recurrent sinusitis (HP:0011108) | 2.16510816 |
| 106 | Axonal loss (HP:0003447) | 2.13726610 |
| 107 | Annular pancreas (HP:0001734) | 2.13626553 |
| 108 | Abnormality of male internal genitalia (HP:0000022) | 2.12610097 |
| 109 | Ulnar bowing (HP:0003031) | 2.12503911 |
| 110 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.12162322 |
| 111 | Tongue fasciculations (HP:0001308) | 2.11822463 |
| 112 | Granulocytopenia (HP:0001913) | 2.11654284 |
| 113 | Eosinophilia (HP:0001880) | 2.11611609 |
| 114 | Prolonged neonatal jaundice (HP:0006579) | 2.10549102 |
| 115 | Growth hormone excess (HP:0000845) | 2.09739500 |
| 116 | Achilles tendon contracture (HP:0001771) | 2.09084132 |
| 117 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.06225311 |
| 118 | Microcytic anemia (HP:0001935) | 2.04833429 |
| 119 | Abnormality of macrophages (HP:0004311) | 2.02940344 |
| 120 | Gingival bleeding (HP:0000225) | 2.02685119 |
| 121 | Increased IgE level (HP:0003212) | 2.01293663 |
| 122 | Selective tooth agenesis (HP:0001592) | 2.01074395 |
| 123 | Increased variability in muscle fiber diameter (HP:0003557) | 2.00516562 |
| 124 | Thin bony cortex (HP:0002753) | 2.00269646 |
| 125 | Abnormality of eosinophils (HP:0001879) | 1.98654597 |
| 126 | Difficulty climbing stairs (HP:0003551) | 1.97926353 |
| 127 | Abnormal platelet function (HP:0011869) | 1.97605741 |
| 128 | Impaired platelet aggregation (HP:0003540) | 1.97605741 |
| 129 | Male infertility (HP:0003251) | 1.95943640 |
| 130 | Hyperthyroidism (HP:0000836) | 1.95906027 |
| 131 | Polygenic inheritance (HP:0010982) | 1.95284281 |
| 132 | Recurrent lower respiratory tract infections (HP:0002783) | 1.95051510 |
| 133 | Interstitial pulmonary disease (HP:0006530) | 1.94669900 |
| 134 | Increased muscle lipid content (HP:0009058) | 1.94444128 |
| 135 | Atelectasis (HP:0100750) | 1.94138577 |
| 136 | Rhabdomyolysis (HP:0003201) | 1.93973143 |
| 137 | Bronchitis (HP:0012387) | 1.93901479 |
| 138 | Aplastic anemia (HP:0001915) | 1.93828031 |
| 139 | Progressive neurologic deterioration (HP:0002344) | 1.93601953 |
| 140 | Reticulocytopenia (HP:0001896) | 1.92608906 |
| 141 | Emphysema (HP:0002097) | 1.92109597 |
| 142 | Abnormality of the Achilles tendon (HP:0005109) | 1.91719117 |
| 143 | Muscle fibrillation (HP:0010546) | 1.90972323 |
| 144 | Recurrent otitis media (HP:0000403) | 1.90702338 |
| 145 | Joint swelling (HP:0001386) | 1.90687949 |
| 146 | Increased mean platelet volume (HP:0011877) | 1.89864905 |
| 147 | Abnormal gallbladder morphology (HP:0012437) | 1.88806287 |
| 148 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.88730430 |
| 149 | Hypoplasia of the thymus (HP:0000778) | 1.88584358 |
| 150 | Amyloidosis (HP:0011034) | 1.88392031 |
| 151 | Gastrointestinal infarctions (HP:0005244) | 1.88265029 |
| 152 | Premature graying of hair (HP:0002216) | 1.88264419 |
| 153 | Menorrhagia (HP:0000132) | 1.86751422 |
| 154 | Flattened epiphyses (HP:0003071) | 1.85879871 |
| 155 | Leukocytosis (HP:0001974) | 1.85343760 |
| 156 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83729307 |
| 157 | Seborrheic dermatitis (HP:0001051) | 1.83404606 |
| 158 | J-shaped sella turcica (HP:0002680) | 1.83165768 |
| 159 | Gastrointestinal dysmotility (HP:0002579) | 1.83099344 |
| 160 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.80844894 |
| 161 | Truncus arteriosus (HP:0001660) | 1.80707279 |
| 162 | Systemic lupus erythematosus (HP:0002725) | 1.80366423 |
| 163 | Thoracic kyphosis (HP:0002942) | 1.79818027 |
| 164 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.79097066 |
| 165 | Hand muscle atrophy (HP:0009130) | 1.76774405 |
| 166 | Abnormality of reticulocytes (HP:0004312) | 1.76689464 |
| 167 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.76474873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.08600168 |
| 2 | MAP3K11 | 3.25463217 |
| 3 | TESK1 | 3.15261056 |
| 4 | ERN1 | 2.95166221 |
| 5 | MAPK15 | 2.80287479 |
| 6 | SMG1 | 2.78258564 |
| 7 | ICK | 2.50395691 |
| 8 | MAP3K6 | 2.46419846 |
| 9 | VRK2 | 2.35482877 |
| 10 | CSK | 2.34321584 |
| 11 | PRPF4B | 2.19652792 |
| 12 | TYK2 | 2.12052043 |
| 13 | MAP3K10 | 2.10964284 |
| 14 | MATK | 2.09991042 |
| 15 | TAOK2 | 2.05876523 |
| 16 | PIM2 | 2.05511362 |
| 17 | BLK | 1.96705192 |
| 18 | ZAP70 | 1.90639249 |
| 19 | TBK1 | 1.87870864 |
| 20 | KIT | 1.87535200 |
| 21 | BTK | 1.74138030 |
| 22 | FLT3 | 1.71293969 |
| 23 | JAK3 | 1.70470745 |
| 24 | PINK1 | 1.69336213 |
| 25 | MAP3K3 | 1.62422938 |
| 26 | EPHA2 | 1.59750023 |
| 27 | DYRK1B | 1.58642630 |
| 28 | IKBKE | 1.58341188 |
| 29 | ARAF | 1.58234514 |
| 30 | GRK6 | 1.58070671 |
| 31 | PIM1 | 1.52287202 |
| 32 | TXK | 1.52005025 |
| 33 | TRIB3 | 1.49512068 |
| 34 | SYK | 1.47455007 |
| 35 | FGFR4 | 1.44095658 |
| 36 | STK10 | 1.38215592 |
| 37 | NME2 | 1.34776690 |
| 38 | MAPK11 | 1.30561706 |
| 39 | IRAK4 | 1.30291733 |
| 40 | DAPK1 | 1.27880881 |
| 41 | KDR | 1.27060422 |
| 42 | TTN | 1.26093063 |
| 43 | BCKDK | 1.22159461 |
| 44 | DDR2 | 1.20769294 |
| 45 | CSF1R | 1.20664183 |
| 46 | LYN | 1.19364413 |
| 47 | MAP3K1 | 1.19267220 |
| 48 | PRKD2 | 1.18178724 |
| 49 | LCK | 1.17485919 |
| 50 | JAK1 | 1.12997249 |
| 51 | SIK3 | 1.12577043 |
| 52 | EEF2K | 1.10836090 |
| 53 | LRRK2 | 1.09547203 |
| 54 | ACVR1B | 1.08834344 |
| 55 | MST1R | 1.08425220 |
| 56 | PRKD3 | 1.07044548 |
| 57 | TEC | 1.06411905 |
| 58 | TESK2 | 1.06121645 |
| 59 | TRPM7 | 1.05199765 |
| 60 | FGR | 1.05090113 |
| 61 | SIK2 | 1.02856272 |
| 62 | IRAK3 | 1.02667211 |
| 63 | ITK | 1.02374785 |
| 64 | PKN2 | 1.00678260 |
| 65 | YES1 | 1.00226662 |
| 66 | ABL2 | 0.99116069 |
| 67 | IKBKB | 0.98027409 |
| 68 | SIK1 | 0.97055901 |
| 69 | BMX | 0.93577714 |
| 70 | TNK2 | 0.90694427 |
| 71 | CDK7 | 0.87510049 |
| 72 | RIPK1 | 0.87248355 |
| 73 | PDPK1 | 0.86617019 |
| 74 | MARK2 | 0.84131132 |
| 75 | RPS6KL1 | 0.84109770 |
| 76 | RPS6KC1 | 0.84109770 |
| 77 | PAK4 | 0.83957565 |
| 78 | RPS6KA6 | 0.83777485 |
| 79 | HIPK2 | 0.83241864 |
| 80 | ATR | 0.81099097 |
| 81 | MAP3K13 | 0.80129174 |
| 82 | MAPKAPK3 | 0.79989528 |
| 83 | MAP3K14 | 0.79237634 |
| 84 | LIMK1 | 0.79100070 |
| 85 | HCK | 0.77807125 |
| 86 | CDK6 | 0.77413312 |
| 87 | FES | 0.76483863 |
| 88 | TAOK1 | 0.75721895 |
| 89 | TAOK3 | 0.75416403 |
| 90 | CDC42BPA | 0.75020231 |
| 91 | PTK6 | 0.74492653 |
| 92 | ILK | 0.73756491 |
| 93 | MAPK12 | 0.72867630 |
| 94 | NEK2 | 0.72115044 |
| 95 | EPHB1 | 0.67575795 |
| 96 | DAPK3 | 0.67035511 |
| 97 | JAK2 | 0.66951568 |
| 98 | LMTK2 | 0.66494396 |
| 99 | RPS6KB2 | 0.66204275 |
| 100 | TLK1 | 0.66168508 |
| 101 | MAP2K3 | 0.64983484 |
| 102 | FGFR3 | 0.64657554 |
| 103 | MAP2K2 | 0.64063514 |
| 104 | BRAF | 0.63346724 |
| 105 | RPS6KA2 | 0.63038538 |
| 106 | IRAK2 | 0.61344387 |
| 107 | DYRK3 | 0.60487686 |
| 108 | CDK4 | 0.59933702 |
| 109 | MARK3 | 0.58058608 |
| 110 | RPS6KA4 | 0.55566657 |
| 111 | TGFBR2 | 0.55322974 |
| 112 | PRKG2 | 0.55238036 |
| 113 | TGFBR1 | 0.54845335 |
| 114 | MAPKAPK2 | 0.53761316 |
| 115 | SCYL2 | 0.53713471 |
| 116 | CHUK | 0.53354489 |
| 117 | TYRO3 | 0.52753957 |
| 118 | UHMK1 | 0.52716096 |
| 119 | STK4 | 0.51672194 |
| 120 | STK38 | 0.50938612 |
| 121 | EIF2AK1 | 0.50850689 |
| 122 | MAPK4 | 0.49805391 |
| 123 | RIPK4 | 0.49726601 |
| 124 | MAP3K7 | 0.49126042 |
| 125 | PAK1 | 0.48747160 |
| 126 | PDK1 | 0.47084051 |
| 127 | PRKD1 | 0.46360230 |
| 128 | EIF2AK3 | 0.45197517 |
| 129 | MTOR | 0.44676528 |
| 130 | STK16 | 0.43446547 |
| 131 | NLK | 0.43191721 |
| 132 | MAP3K8 | 0.42967883 |
| 133 | RAF1 | 0.42798358 |
| 134 | AURKA | 0.41782293 |
| 135 | PRKCD | 0.41587192 |
| 136 | MAP2K6 | 0.41481966 |
| 137 | MAPK3 | 0.41126484 |
| 138 | GRK5 | 0.38564277 |
| 139 | PDGFRA | 0.35086224 |
| 140 | PTK2 | 0.33209455 |
| 141 | CHEK2 | 0.31564643 |
| 142 | RPS6KA1 | 0.31449546 |
| 143 | PTK2B | 0.30793331 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.36561567 |
| 2 | Base excision repair_Homo sapiens_hsa03410 | 3.40836600 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.30076919 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.23580509 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.25254219 |
| 6 | Sulfur relay system_Homo sapiens_hsa04122 | 1.90423203 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.85055461 |
| 8 | Measles_Homo sapiens_hsa05162 | 1.82977014 |
| 9 | Ribosome_Homo sapiens_hsa03010 | 1.79573866 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.75133071 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.72069407 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.62773688 |
| 13 | Shigellosis_Homo sapiens_hsa05131 | 1.60479903 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 1.60348630 |
| 15 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.57835990 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.56887297 |
| 17 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.54257851 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.53513412 |
| 19 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.52456454 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.51944719 |
| 21 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.48863156 |
| 22 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.46544617 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.41320579 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.41118134 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.35906974 |
| 26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.32195079 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.31458798 |
| 28 | Endocytosis_Homo sapiens_hsa04144 | 1.27092569 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25337583 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.24460771 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.23735970 |
| 32 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.22999668 |
| 33 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.22543929 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.20366401 |
| 35 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.14057842 |
| 36 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.11492369 |
| 37 | Spliceosome_Homo sapiens_hsa03040 | 1.11391849 |
| 38 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.11318845 |
| 39 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.10860172 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10641054 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07058876 |
| 42 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.04081101 |
| 43 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.03721983 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.03453742 |
| 45 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.02946463 |
| 46 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.01580852 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 1.00876322 |
| 48 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.00321129 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.00181748 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.00112905 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.98536254 |
| 52 | Allograft rejection_Homo sapiens_hsa05330 | 0.98052556 |
| 53 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.97519032 |
| 54 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96794138 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.95223949 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.94267710 |
| 57 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.93641882 |
| 58 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.92547637 |
| 59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.92053308 |
| 60 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.91320515 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.91316029 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91240231 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.90488586 |
| 64 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.88731741 |
| 65 | Carbon metabolism_Homo sapiens_hsa01200 | 0.87907264 |
| 66 | Influenza A_Homo sapiens_hsa05164 | 0.87765054 |
| 67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86508562 |
| 68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85321288 |
| 69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.83965744 |
| 70 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.83843899 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.81895078 |
| 72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.80097755 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78595939 |
| 74 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76705210 |
| 75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.75763753 |
| 76 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.73326854 |
| 77 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.73157021 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.73005516 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72921025 |
| 80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.72810132 |
| 81 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71905557 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.71865551 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71526680 |
| 84 | Tuberculosis_Homo sapiens_hsa05152 | 0.70511485 |
| 85 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.69667787 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69563122 |
| 87 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.69265094 |
| 88 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68743039 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68505219 |
| 90 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.68283929 |
| 91 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.67936812 |
| 92 | Prion diseases_Homo sapiens_hsa05020 | 0.67696789 |
| 93 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.63809892 |
| 94 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63708255 |
| 95 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.63237517 |
| 96 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.62295751 |
| 97 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.62099824 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.61111165 |
| 99 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.59626647 |
| 100 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59464854 |
| 101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59131680 |
| 102 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.58942276 |
| 103 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58883855 |
| 104 | Pertussis_Homo sapiens_hsa05133 | 0.58795071 |
| 105 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58162543 |
| 106 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57928812 |
| 107 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.57686129 |
| 108 | Proteasome_Homo sapiens_hsa03050 | 0.57382500 |
| 109 | RNA transport_Homo sapiens_hsa03013 | 0.57115876 |
| 110 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.54759470 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.54517657 |
| 112 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53061561 |
| 113 | ABC transporters_Homo sapiens_hsa02010 | 0.52228668 |
| 114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51907601 |
| 115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51137834 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50839502 |
| 117 | Salmonella infection_Homo sapiens_hsa05132 | 0.49217654 |
| 118 | Cell cycle_Homo sapiens_hsa04110 | 0.48842978 |
| 119 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.48317078 |
| 120 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.47233039 |
| 121 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47152429 |
| 122 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.46186614 |
| 123 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45304829 |
| 124 | Bladder cancer_Homo sapiens_hsa05219 | 0.44891378 |
| 125 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.44660426 |
| 126 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43548644 |
| 127 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.42228326 |
| 128 | Amoebiasis_Homo sapiens_hsa05146 | 0.41811456 |
| 129 | Platelet activation_Homo sapiens_hsa04611 | 0.41133931 |
| 130 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.40723427 |
| 131 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40678815 |
| 132 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.40626076 |
| 133 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.39587001 |
| 134 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.39370507 |

